Poliskey Therapy Pllc in Frederic, MI - Marriage & Family Therapist

Poliskey Therapy Pllc is a mental health clinic (Marriage & Family Therapist) in Frederic, Michigan. The current practice location for Poliskey Therapy Pllc is 11284 Sherwood Dr, Frederic, Michigan. For appointments, you can reach them via phone at (248) 212-8295. The mailing address for Poliskey Therapy Pllc is 11284 Sherwood Dr, Frederic, Michigan and phone number is () -.

Poliskey Therapy Pllc is licensed to practice in * (Not Available) (license number ) and its NPI number is 1881382794. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (248) 212-8295.

Contact Information

	Poliskey Therapy Pllc
	11284 Sherwood Dr Frederic MI 49733-9628
	(248) 212-8295
	Not Available

Mental Health Clinic Profile

Full Name	Poliskey Therapy Pllc
Speciality	Marriage & Family Therapist
Location	11284 Sherwood Dr, Frederic, Michigan
Authorized Official Name and Position	John Poliskey (OWNER)
Authorized Official Contact	2482128295
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Poliskey Therapy Pllc 11284 Sherwood Dr Frederic MI 49733-9628 Ph: () -	Poliskey Therapy Pllc 11284 Sherwood Dr Frederic MI 49733-9628 Ph: (248) 212-8295

NPI Details:

NPI Number	1881382794
Provider Enumeration Date	04/27/2023
Last Update Date	04/27/2023
Certification Date	04/27/2023

Medical Identifiers

Medical identifiers for Poliskey Therapy Pllc such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881382794	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	(* (Not Available))	Primary

News Archive

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

STMicroelectronics, the leading supplier of MEMS devices for consumer and portable applications, and Bluechiip Limited, an innovative early-stage company that has developed a groundbreaking tracking solution, today announced that the two companies are to cooperate in the manufacturing of unique MEMS-based tracking tags, aimed at a range of different markets, but initially in healthcare, such as biobanks.

Safety concerns over testosterone gel prompt FDA to require label changes

The U.S. Food and Drug Administration today announced that it is requiring manufacturers of two prescription topical testosterone gel products, AndroGel 1% and Testim 1%, to include a boxed warning on the products' labels.

Researchers discover how genetic mutations cause rare human diseases

Researchers at the University of California, San Francisco and in Michigan, North Carolina and Spain have discovered how genetic mutations cause a number of rare human diseases, which include Meckel syndrome, Joubert syndrome and several other disorders.

Research shows link between absence of RB protein and long-term survival rates in lung cancer patients

November is Lung Cancer Awareness Month, highlighting the number one cause of cancer-related death in North America. While prognosis for the most common form, adenocarcinoma, has remained poor, new research has shown a link between the absence of a specific protein and improved patient outcomes.

Investigational antiviral superior to standard of care for treating COVID-19 patients

The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in The New England Journal of Medicine.

Poliskey Therapy Pllc - Mental Health Clinic in Frederic, MI